Non-squamous Non-small-cell Lung Cancer

Explore clinical trials studying Non-squamous Non-small-cell Lung Cancer. Study availability and eligibility vary by location and protocol.

7 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Non-squamous Non-small-cell Lung Cancer trial results

Recruiting

A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers

NCT05403554

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +26 more
Locations: Institut Curie Paris, France

Hôpital Européen Georges Pompidou Paris, France

Centre Eugène Marquis Rennes, France

Gustave Roussy Villejuif, France, France

View Trial Details

Completed

Study of Crizotinib for ROS1 and MET Activated Lung Cancer

NCT04084717

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer

NCT05318443

Conditions: Non-squamous Non-small-cell Lung Cancer
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Completed

Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer

NCT04012619

Conditions: Anlotinib, Non-squamous Non-small-cell Lung Cancer
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Completed

A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer

NCT00152477

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations: Budapest, Hungary

Deszk, Hungary

Mátraháza, Hungary

Nyíregyháza, Hungary

View all 21 locations

View Trial Details

Active, Not Recruiting

Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

NCT04958811

Conditions: Lung Diseases, Lung Neoplasms, Neoplasms, +5 more
Locations: MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States

John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Active, Not Recruiting

Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations

NCT05258279

Conditions: EGFR Activating Mutation, Non-squamous Non-small-cell Lung Cancer
Locations: Juntendo Urayasu Hospital Urayasu, Chiba, Japan

St. Marianna University Hospital Kawasaki, Kanagawa, Japan

Kanagawa Cardiovascular and Respiratory Center Yokohama, Kanagawa, Japan

Kanagawa Cancer Center Yokohama, Kanagawa, Japan

View Trial Details

Non-squamous Non-small-cell Lung Cancer

Non-squamous Non-small-cell Lung Cancer trial results

A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Study of Crizotinib for ROS1 and MET Activated Lung Cancer

A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer

Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer

A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer

Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations

Related conditions